Elos Medtech AB (publ)

OM:ELOS B Rapport sur les actions

Capitalisation boursière : SEK 5.7b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Elos Medtech Bilan de santé

Santé financière contrôle des critères 6/6

Elos Medtech possède un total de capitaux propres de SEK788.2M et une dette totale de SEK407.1M, ce qui porte son ratio d'endettement à 51.6%. Son actif total et son passif total sont SEK1.6B et de SEK772.0M. L'EBIT de Elos Medtech est SEK136.9M ce qui fait que son ratio de couverture des intérêts 3.2. Elle dispose de liquidités et de placements à court terme de SEK117.3M.

Informations clés

51.6%

Ratio d'endettement

SEK 407.10m

Dette

Ratio de couverture des intérêts3.2x
Argent liquideSEK 117.30m
Fonds propresSEK 788.20m
Total du passifSEK 772.00m
Total des actifsSEK 1.56b

Mises à jour récentes de la santé financière

We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

Mar 24
We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Dec 13
Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Recent updates

Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)

Oct 11
Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)

Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?

May 23
Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?

Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock

May 10
Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock

Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)

Apr 17
Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)

We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

Mar 24
We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?

Mar 11
Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?

The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

Feb 28
The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Feb 24
Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

Feb 11
Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

Jan 31
When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Jan 18
How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

Jan 06
Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?

Dec 26
Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?

Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Dec 13
Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential

Nov 30
Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential

Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 17
Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de ELOS B ( SEK577.9M ) dépassent ses passifs à court terme ( SEK289.8M ).

Passif à long terme: Les actifs à court terme de ELOS B ( SEK577.9M ) dépassent ses passifs à long terme ( SEK482.2M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de ELOS B ( 36.8% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de ELOS B a été réduit de 57.1% à 51.6% au cours des 5 dernières années.

Couverture de la dette: La dette de ELOS B est bien couverte par le flux de trésorerie opérationnel ( 23.4% ).

Couverture des intérêts: Les paiements d'intérêts de ELOS B sur sa dette sont bien couverts par l'EBIT ( 3.2 x couverture).


Bilan


Découvrir des entreprises saines